Advertisement
Screener

SYNLOGIC, INC. (SYBX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

SYNLOGIC, INC. Cash Flow Breakdown

Cash flow breakdown shows where SYNLOGIC, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $4.36M went out.
  • Fiscal year ended 2025-12-31: from investing, $167.00K came in.
  • Fiscal year ended 2025-12-31: from financing, $0.00 came in.
  • Fiscal year ended 2025-12-31: change in cash, $4.19M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$4.36M$167.00K-$4.19M
2024-12-31-$31.66M$25.34M-$6.15M
2023-12-31-$51.61M$38.77M$0.00$20.94M*$8.10M
2022-12-31-$56.89M$58.35M-$2.52M$0.00$0.00-$577.00K
2021-12-31-$52.20M-$53.25M$0.00-$73.00K$81.04M$8.41M*-$16.07M
2020-12-31-$39.55M$32.48M$13.39M*$6.32M
2019-12-31-$75.47M$10.80M$57.00M$22.61M*$14.93M
2018-12-31-$42.47M-$87.20M$82.67M-$47.19M
2017-12-31-$31.05M$9.28M$5.00K$66.67M*$44.90M
2016-12-31-$20.41M-$1.83M$0.00$30.65M*$8.41M
2015-12-31-$21.14M-$251.00K$60.28M$41.50M*
2014-12-31-$13.97M-$102.00K$0.00
2013-12-31-$6.50M-$7.00K$1.00K$16.42M*

Each quarter (3 month)

Quarter endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$922.00K*$0.00*
2026-03-31-$563.00K$0.00-$563.00K
2025-12-31-$923.00K*$0.00*
2025-09-30-$1.44M*$0.00*
2025-06-30-$399.00K*$155.00K*
2025-03-31-$1.60M$12.00K-$1.59M
2024-12-31-$568.00K*$30.00K*
2024-09-30-$648.00K*$72.00K*
2024-06-30-$15.01M*$8.96M*
2024-03-31-$15.44M$16.28M$862.00K
2023-12-31-$5.53M*-$14.63M*$19.58M*
2023-09-30-$12.96M*-$8.83M*
2023-06-30-$11.63M*$31.96M*
2023-03-31-$21.50M$30.27M$913.00K*$9.68M
2022-12-31-$12.39M*$14.86M*-$2.23M*
2022-09-30-$15.45M*$119.00K*
2022-06-30-$13.57M*$23.61M*
2022-03-31-$15.48M$19.76M$4.41M
2021-12-31-$13.06M*-$33.31M*$0.00*-$125.00K*
2021-09-30-$13.82M*-$1.35M*$0.00*$48.59M*
2021-06-30-$11.35M*-$18.75M*-$8.00K*$32.64M*
2021-03-31-$13.98M$154.00K-$65.00K$8.08M*-$5.80M
2020-12-31-$9.89M*$7.11M*$8.47M*
2020-09-30-$8.20M*$2.46M*$1.21M*
2020-06-30-$8.99M*$17.10M*$3.79M*
2020-03-31-$12.48M$5.82M-$6.73M
2019-12-31-$11.21M*$10.01M*-$1.00K*
2019-09-30-$10.55M*$20.62M*$14.00K*
2019-06-30-$40.59M*-$37.51M*$79.79M*
2019-03-31-$13.12M$17.68M$4.49M
2018-12-31-$8.96M*$2.92M*$0.00*
2018-09-30-$9.67M*$309.00K*$0.00*
2018-06-30-$10.80M*-$18.56M*$28.91M*
2018-03-31-$13.03M-$71.87M$53.75M-$31.25M
2017-12-31-$9.02M*-$11.49M*
2017-09-30-$7.49M*$21.18M*
2017-06-30-$11.32M*-$4.30M*$0.00*$67.17M*
2017-03-31-$3.22M$3.88M$25.00K$19.56M
2016-12-31-$1.18M*$41.70M*$7.00K*$30.63M*
2016-09-30$266.00K*$43.09M*$0.00*$30.88M*
2016-06-30-$5.13M*-$16.96M*$9.00K*
2016-03-31-$8.97M-$27.86M$0.00
2015-12-31-$6.62M*-$64.00K*$0.00*$60.69M*
2015-09-30-$5.32M*-$129.00K*$32.00K*
2015-06-30-$4.65M*-$53.00K*$15.00K*$6.14M*
2015-03-31-$4.55M-$5.00K$20.00K$35.35M*
2014-12-31-$3.38M*-$72.00K*$0.00*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bolt Biotherapeutics, Inc. (BOLT)United States$0.007B-0.26
Enveric Biosciences, Inc. (ENVB)United States$0.007B-0.63
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Ernexa Therapeutics Inc. (ERNA)United States$0.006B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
Pulmatrix, Inc. (PULM)United States$0.006B
EXICURE, INC. (XCUR)United States$0.008B-1.54